Gene therapy for refractory angina and cell therapy for heart failure: experience of a Brazilian research group-Reference-Cited by-同舟云学术

Gene therapy for refractory angina and cell therapy for heart failure: experience of a Brazilian research group

Published:2019-07-05 Issue:1-2 Volume:27 Page:40-50
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Sant’Anna Roberto Tofani,Eibel Bruna,Markoski Melissa Medeiros^ORCID,Rodrigues Clarissa Garcia,de Salles Felipe Borsu,Giusti Imarilde Inês,Nesralla Ivo Abrahão,Nardi Nance Beyer^ORCID,Kalil Renato Abdala Karam

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/s41434-019-0087-2.pdf

Reference70 articles.

1. Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev. 2017;3:7–11.

2. Cook C, Cole G, Asaria P, Jabbour R, Francis DP. The annual global economic burden of heart failure. Int J Cardiol. 2014;171:368–76.

3. Stewart S, MacIntyre K, Hole DJ, Capewell S, McMurray JJ. More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail. 2001;3:315–22.

4. Chen J, Normand SL, Wang Y, Krumholz HM. National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998–2008. JAMA. 2011;306:1669–78.

5. Sanganalmath SK, Bolli R. Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ Res. 2013;113:810–34.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Electrical impedance-based contractile stress measurement of human iPSC-Cardiomyocytes;Biosensors and Bioelectronics;2020-10

2. Stem Cells for Cardiovascular Diseases Revisited in 2019;Brazilian Journal of Cardiovascular Surgery;2019